Eosinophilia Induced by Recombinant Human Interleukin-5 in Hamsters
Author Information
Author(s): M. Minnicozzi, W. N. Durbin, D. Kim, G. J. Gleich, J. Wagner, R. W. Egan
Primary Institution: Schering-Plough Research Institute
Hypothesis
Does recombinant human IL-5 promote tissue eosinophilia and affect vascular function?
Conclusion
Repetitive administration of recombinant human IL-5 significantly increases eosinophil numbers in hamster cheek pouch membranes but does not alter vascular permeability.
Supporting Evidence
- Repetitive injections of rHu IL-5 resulted in a 7-fold increase in eosinophils in the ipsilateral cheek pouch.
- Denatured rHu IL-5 did not elevate eosinophil levels in the tissues.
- Immunofluorescence confirmed that recruited eosinophils had not degranulated.
Takeaway
The study shows that a special protein called IL-5 can make more eosinophils, which are a type of white blood cell, gather in a part of a hamster's cheek, but it doesn't change how well the blood vessels work.
Methodology
Male golden Syrian hamsters received repetitive subcutaneous injections of recombinant human IL-5, and eosinophil counts were measured in cheek pouch membranes and peritoneal lavage.
Limitations
The study was conducted on hamsters, which may not fully represent human responses.
Participant Demographics
Male golden Syrian hamsters, weighing 80-100g.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website